Recorded October 6, 2022 | On-Demand Webinar
Major international emergencies such as the COVID-19 pandemic and the ongoing conflict in Ukraine have led to supply chain disruptions for FDA-regulated companies. During this webinar, speakers will discuss: 1) specific impacts of supply chain disruptions on FDA-regulated industry; 2) findings from the FDA’s 2021 100-day review of supply chains and reports on outcomes one year later; 3) ways that companies can mitigate risks posed by unexpected shortages or problems getting access to components of regulated products from third-party manufacturers; 4) federal efforts to stimulate domestic manufacturing of critical medical products and other FDA-regulated components; and 5) how organizations have rethought and rebuilt their supply chains to be more agile, efficient, and sustainable.